Insider · CIK 0001685893
Arun Swarup Menawat
Files at AIFF (FIREFLY NEUROSCIENCE, INC.), STXS (Stereotaxis, Inc.), PROF (Profound Medical Corp.). First filing May 20, 2025, latest May 20, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PROF: Profound Medical Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | PROFbuy Profound Medical Corp. | $100k 22,030 shares | +4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | AIFF FIREFLY NEUROSCIENCE, INC. | AGrant or award Deferred Stock Unitsderivative | +126,050 | $0.00 | $0 | 216,609 | 13 d ago |
| Oct 28, 2025 | AIFF FIREFLY NEUROSCIENCE, INC. | AGrant or award Deferred Stock Unitsderivative | +73,892 | $0.00 | $0 | 90,559 | Oct 30, 2025 |
| Jul 1, 2025 | STXS Stereotaxis, Inc. | AGrant or award Common Stock | +43,668 | $0.00 | $0 | 945,509 | Jul 3, 2025 |
| May 19, 2025 | AIFF FIREFLY NEUROSCIENCE, INC. | AGrant or award Restricted Stock Unitsderivative | +125,000 | $0.00 | $0 | 125,000 | May 20, 2025 |
| May 15, 2025 | PROF Profound Medical Corp. | POpen-market purchase Common Shares | +10,003 | $4.33 | $43k | 575,062 | May 20, 2025 |
| May 16, 2025 | PROF Profound Medical Corp. | POpen-market purchase Common Shares | +12,027 | $4.73 | $57k | 587,089 | May 20, 2025 |
| Mar 10, 2025 | AIFF FIREFLY NEUROSCIENCE, INC. | AGrant or award Deferred Stock Unitsderivative | +16,667 | $0.00 | $0 | 16,667 | Mar 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.